chrysene; (r,t,c,c)- r-9,t-10,c-11,c-12-tetrahydroxy-9,10,11,12-tetrahydrobenzo[c] -tetraol, r-11,t-12,t-13,c-14-tetrahydroxy-11,12,13,14-tetrahydrobenzo[g] r-11,t-12,c-13,t-14-tetrahydroxy-11,12,13,14-tetrahydrobenzo[g]chrysene; (r,t,c,c)- -tetraol, r-11,t-12,c-13,c-14-tetrahydroxy-11,12,13,14-tetrahydrobenzo[g] r-11,t-12,t-13,c-14-tetrahydroxy-11,12,13,14-tetrahydrodibenzo[a,l]pyrene; (r,t,c,t)-DB [a,l]P-tetraol, r-11,t-12,c-13,t-14-tetrahydroxy-11,12,13,14-tetrahydrodibenzo[a,l]pyrene; (r,t,c,c)-DB [a,l]P-tetraol, r-11,t-12,c-13,c-14-tetrahydroxy-11,12,13,14-tetrahydrodibenzo[a,l]pyrene; DE, dihydrodiol epoxide; DMSO, dimethyl sulfoxide; EI, electron impact; EtOAc, ethyl acetate; FD, field desorption; HPLC, high-performance liquid chromatography; MC, 3-methylcholanthrene; NMR, nuclear magnetic resonance; PAH, polycyclic aromatic hydrocarbons.
Introduction
Polycyclic aromatic hydrocarbons (PAH*) are widely distributed environmental pollutants (1) and include a large number of compounds with strong tumorigenic activity (1, 2) . Therefore they may be involved in human cancer etiology (3) . Their genotoxicity is caused by the attempt of the contaminated organism to transform these lipophilic and chemically relatively inert compounds into more water-soluble and, therefore, excretable metabolites. This biotransformation is predominantly catalyzed by hepatic enzymes (4, 5) . In this pathway, electrophilically reactive arene oxides and dihydrodiol epoxides are generated in significant amounts as has been demonstrated for various PAH (6, 7) . These metabolites are able to covalently react with genomic DNA and, consequently, generation of stable adducts is considered to play an important role in mutagenesis and carcinogenesis initiated by PAH (8) (9) (10) (11) .
It has been shown for a number of so-called bay region PAH including benzo[a]pyrene (B[a]P) (12) and dibenz[a,h]-anthracene (DB[a,h]A) (13, 14) that their carcinogenic activity is causatively linked to the metabolic formation of substantial amounts of bay region anti-dihydrodiol epoxides and possibly further oxidized metabolites (6, 15) . However, for PAH, which possess the structural element of a fjord region, the situation is much less clear. Despite the fact that the fjord region syn-and anti-dihydrodiol epoxides of benzo[c]phenanthrene (B[c]PhDEs) are both among the most powerful carcinogenic PAH dihydrodiol epoxides yet tested in rodents (16) (17) (18) , the parent hydrocarbon is only weakly active on mouse skin (18) . This can be rationalized in part by great variations in the regioselectivity of its metabolism on mouse skin (19) , which leads to fjord region dihydrodiol epoxides only in trace amounts (15, 19) . In contrast to B[c]Ph, the isomeric pentacyclic fjord region aromatic hydrocarbons benzo Figure 1 ) have been reported to be moderate carcinogens (2, 20) , whereas the hexacyclic fjord region hydrocarbon dibenzo [a,l] pyrene (DB[a,l]P) (cf. Figure 1 ), identified in cigarette smoke condensate (21) , coal combustion emissions (22) or soil and sediment extracts (23) , has been proven to be an exceptionally strong tumorigenic and toxic compound (24, 25) . For all three PAH it has been demonstrated that their fjord region syn-and anti-dihydrodiol epoxides display exceptionally high intrinsic mutagenic activity in Salmonella typhimurium as well as in Chinese hamster V79 cells (26, 27) . The strong mutagenic activity has been attributed in part to a relatively high level of DNA adduct formation (28) . Furthermore, the fjord region anti-B[g]CDE and anti-DB[a,l]PDE have been shown to be potent carcinogens in newborn mice (29) , in rat mammary gland (17) and, for the latter dihydrodiol epoxide, also in mouse skin (30) . Further evidence that the fjord region syn-and anti-dihydrodiol epoxides are putative ultimate carcinogenic metabolites of B[g]C and DB[a,l]P stems from the analysis of DNA adducts formed in mouse skin (31, 32) . DNA adducts of syn-and anti-DB[a,l]PDE have also been identified in human and mouse cell cultures treated with DB[a,l]P (32-34) or after microsomal activation of the parent PAH (35, 36) . Additionally, syn-and anti-B[g]CDE-DNA adducts have been detected in human mammary carcinoma MCF-7 cells after exposure to B[g]C (37) .
Metabolism studies with B[g]C (38) and DB[a,l]P (39) using rat liver microsomes from 3-methylcholanthrene (MC)-treated rats revealed that the trans-11,12-dihydrodiols ( Figure 1 ) has also been included in this study to further extend our knowledge on the metabolic activation of dihydrodiols with a double bond in the fjord region. Rat liver microsomes 640 from Aroclor 1254-treated animals have been employed as a metabolizing system. Aroclor 1254 was selected as a mixedtype inducer allowing to relate the results of the present metabolism study to previous studies on DNA adduct measurement by 32 P-postlabeling and on the mutagenic potency of the dihydrodiols, in which the identical metabolizing system was used (40) . Incubation of 3 H-labeled dihydrodiols synthesized via the corresponding o-quinones made it possible to quantitate the total metabolic conversion. Detection and quantitation of the unstable syn-and anti-dihydrodiol epoxides were indirectly performed by identifying the tetraols, which were formed by acidic hydrolysis (cf. Figure 1 ). This methodology requires tetraols with different stereochemistry as reference compounds. Consequently, the synthesis and spectroscopic characterization of the metabolically relevant tetraols formed by hydrolysis of the fjord region dihydrodiol epoxides of each of the three PAH were also undertaken.
Materials and methods

Instrumentation
Melting points were determined on a Büchi 510 apparatus using unsealed capillary tubes and are uncorrected. 1 H-nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AM 400 (Bruker, Karlsruhe, Germany) operating at 400 MHz. Chemical shifts (δ) are reported as downfield from tetramethylsilane. UV spectra were obtained with a Shimadzu MPS-2000 spectrophotometer (Shimadzu, Düsseldorf, Germany). The electron impact (EI) mass spectra (direct inlet mode at 70 eV) and the field desorption (FD) mass spectra were run on a CH7A and on a MAT 90 mass spectrometer (Finnigan, Bremen, Germany), respectively. Preparative high-performance liquid chromatography (HPLC) purifications were conducted on a Du Pont 830 using a silica gel (Polygosil C 18 , 5 µm; Knauer, Berlin, Germany) column (16ϫ250 mm). Analytical separations of metabolites and purification of radiolabeled dihydrodiols were performed by HPLC using a Spectra-Physics SP 8700 solvent delivery system (Thermo Separation Products, Darmstadt, Germany) in co-operation with an LKB 2140 diode array detector (Pharmacia, Freiburg, Germany) or with a system that consisted of two high-pressure pumps, model 740; the gradient programmer model 744; and a UV detector model 230 (Spectra-Physics) operating at 280 nm. Polygosil 60 (5 µm) and LiChrospher RP-18 (5 µm) columns (4ϫ250 mm or 8ϫ250 mm; Knauer, Berlin, Germany) were used as stationary phases in analytical HPLC. A Sigma 4K10 centrifuge (Braun, Melsungen, Germany) was applied for the separation of the organic and aqueous phases to accomplish the extraction protocol after microsomal biotransformation of the substrates.
Chemicals
Sodium borotritide with a specific activity of 18.5 GBq (500 mCi)/mmol was obtained in sealed glass tubes from Amersham Buchler (Braunschweig, Germany). Quantification of radiolabeled compounds and metabolites were accomplished by liquid scintillation measurement in a Packard Tri-Carb 300C Liquid Scintillation System (Canberra Packard, Frankfurt/M., Germany) after addition of 7-10 vol. of Aquasafe 300 Plus (Zinsser Analytic, Frankfurt/M., Germany). Aroclor 1254 was obtained from Bayer (Leverkusen, Germany). Biochemicals were from Boehringer (Mannheim, Germany) and tricaprylin was from Sigma Chemie (Deisenhofen, Germany). All other chemicals of analytical grade were purchased from Merck (Darmstadt, Germany) or Sigma Chemie.
Synthesis of 3 H-labeled dihydrodiols
The synthesis of the required o-quinones of B[c]C, B[g]C and DB[a,l]P was performed as described (20, 27 3 H-labeled transdihydrodiols was determined by HPLC with UV-detection (280 nm) using LiChrospher RP-18 (5 µm; 4ϫ250 mm) as a stationary phase and a linear gradient from acetonitrile/water (1:9, v/v) to methanol in 80 min as a mobile phase at a flow rate of 0.8 ml/min. The total eluate of one chromatographic run was collected in 0.5 min fractions, which were mixed with liquid scintillator and counted in a liquid scintillation counter. The radiochemical purity is given as the percentage of total radioactivity that elutes within the same elution volume as the pure unlabeled compound. Quantification of the dihydrodiol was achieved using an integration area versus concentration curve (external standardization). Finally, the radioactivity and the amount of each compound in the eluted peak allowed the calculation of its specific activity. The dihydrodiols were stored at -70°C until used in incubations.
Reduction [g]C-11,12-dihydrodiol were in the same range as in the case of the non-labeled dihydrodiols (ജ98%; cf. section below). The detection of radioactivity in the fractions eluting in front and after the individual dihydrodiol peak might be due to an increased instability of the newly generated C-3 H-bonds of both mentioned dihydrodiols. Besides this low radioactive background, no evidence for conspicuous impurities of the radioactive labeled compounds could be found either by spectrophotometrical or by radiometrical detection during HPLC analysis.
Synthesis of unlabeled dihydrodiols and tetraols
The synthesis of the dihydrodiols and the diasteromeric fjord region dihydrodiol epoxides of B At 6 days after the treatment liver microsomes were prepared as previously described (42) . The CYP content was measured spectrophotometrically according to Omura and Sato (43) .
Metabolism of B[c]C-trans-9,10-, B[g]C-trans-11,12-and DB[a,l]P-trans-11,12-dihydrodiol
Each dihydrodiol was incubated at 37°C in a phosphate-buffered solution (pH 7.4; total volume: 2.0 ml) containing the following reagents: 950 µl KCl (150 mM, pH 7.4), 200 µl sodium phosphate buffer (0.5 M, pH 7.4), 100 µl MgCl 2 (100 mM), 500 µl of an NADPH-regenerating system [32 mM glucose-6-phosphate, 2.4 mM NADP ϩ , 17.2 µg (2.4 units)/ml glucose-6-phosphate dehydrogenase in an isotonic solution of KCl, pH 7.4] and a suspension of microsomes (ca. 200 µl) equivalent to a total amount of 5 nmol CYP. After the incubation mixture was kept for 2 min at 37°C in an open vessel, the incubation was started by adding 160-260 nmol radioactive dihydrodiol (depending on the specific activity, see above) or 160 nmol non-labeled dihydrodiol dissolved in 50 µl DMSO. After shaking (80 min -1 ) at 37°C the incubation was stopped by adding 150 µl of 1.5 M perchloric acid, which lowered the pH of the mixture to 2-3. At 3 h later, at room temperature, the reaction mixture was neutralized with 100 µl of Tris-saturated water. The substrate and metabolites were then extracted by adding 3 ml of ice-cold EtOAc followed by vortexing for 1 min and separation of the organic phase by centrifugation at 3500 r.p.m. The extraction was repeated twice with 2.0 ml of EtOAc. The combined organic phases were dried over anhydrous MgSO 4 and evaporated to dryness with a gentle stream of N 2 at 35°C. The residue was stored at -20°C until HPLC analysis, for which the sample was redissolved in 80 µl DMSO. Aliquots of 20 µl were analyzed by HPLC using a LiChrospher-100 RP-18 (5 µm) column (4ϫ250 mm). Elution conditions were as follows: linear gradient of acetonitrile/methanol/water (10:30:60, v/ v/v) in 100 min to 100% methanol at a flow rate of 0.8 ml/min. Eluted metabolites were photometrically detected at a wavelength of 280 nm and, in the experiments using 3 H-labeled dihydrodiols, radiometrically quantified after collection of 30 s fractions. 'Total metabolic conversion' (Table II) was calculated from the total radioactivity that was eluted prior to and after the dihydrodiols in HPLC, and the amount of radioactivity that remained in the aqueous phase after EtOAc extraction. The latter fraction, termed 'watersoluble metabolites', contains hydrophilic and protein-bound metabolites. Tetraols formed as hydrolysis products of the fjord region dihydrodiol epoxides of the three PAH were identified by co-chromatography with synthetic reference compounds and comparison of their UV spectra (see above). Their amount was photometrically determined at 280 nm from a calibration curve obtained by plotting the amounts of synthetic tetraols versus their peak areas (external standardization).
Results and discussion
Sterically hindered syn-and anti-dihydrodiol epoxides of PAH are important carcinogenic metabolites that show a relatively low chemical stability in aqueous solutions and, therefore, undergo hydrolysis to structurally different tetraols particularly under acidic conditions (44) . Consequently, the tetraols are valuable marker compounds that indicate the intermediate enzymatic formation of dihydrodiol epoxides, as has been demonstrated in numerous in vitro metabolism studies with trans-dihydrodiols [reviewed in (45) ]. Also more recently, analysis of tetraols in the urine of rats has been achieved by improved analytical techniques, which indicates the formation of intermediate dihydrodiol epoxides in vivo upon exposure to PAH (46) . Investigations of the stereochemistry of the formed tetraols allows the determination of stereoselectivity by which the CYP-catalyzed oxidation of the precursor trans-dihydrodiol proceeds. Moreover, tetraols as their acetates, have been demonstrated to be useful model compounds for the structural elucidation of adducts of dihydrodiol epoxides with purine bases in DNA (8, 47) .
In the present study, acidic hydrolysis of the fjord region syn-and anti-dihydrodiol epoxides of B[c]C, B[g]C and DB[a,l]P has been used to obtain a set of tetraols of each PAH (Figure 1 ) as spectroscopically characterized reference compounds for subsequent metabolism studies (cf. below). Hydrolysis of the anti-diastereomers occurred almost exclus-ively via trans opening of the oxirane ring to produce (r,t,t,c)-tetraols ( Figure 1) . The preponderate formation of (r,t,t,c)-tetraols has also been reported for the hydrolysis of anti-B (48) show a common feature in that they all adopt preferentially an aligned conformation with pseudoequatorially oriented hydroxyl groups. As has been pointed out previously by Sayer et al. (48) , conformational effects and the stability of the intermediate carbocation strongly influence the product ratios from the hydrolysis of dihydrodiol epoxides. Accordingly, the high proportion of (r,t,
c,c)-tetraol formation from syn-B[c]CDE, syn-B[g]CDE and syn-DB[a,l]PDE
can be explained by a stereoelectronically favored reaction pathway via a carbocation formed from the preferred aligned conformer.
Synthesis and spectral characterization of tetraols
The assignment of the stereochemistry of (r,t,c,c)-and (r,t,c,t)-tetraols obtained from each syn-dihydrodiol epoxide has been accomplished on the basis of the differences seen for the sets of coupling constants of the methine protons and by comparison with the tetraols of known stereochemistry derived from B[c]Ph (48) . Partial 400 MHz-1 H-NMR data of the synthesized fjord region tetraols are compiled in Table I (52) for cyclic systems. The preferred conformations of the stereoisomeric tetraols were concluded from each set of calculated dihedral angles (Figures 2 and 3) . In previous studies the assignments of cis and trans stereochemistry of the hydrolysis products has also been made on the basis of the general finding that in the 1 H-NMR spectra of the tetraacetates of the cisproducts the resonances of the methine protons in the bay or fjord region are found further downfield than for the transproducts. This criterion does not hold true for the spectra of the tetraols (see δ values for H d in Table I ). However, by comparing in the present study a series of (r,t,c,c)-and (r,t,c,t)-tetraols derived from fjord region syn-dihydrodiol epoxides a characteristic downfield shift (0.33-0.49 p.p.m.) was consistently observed for the aromatic protons across the fjord region in the (r,t,c,c)-tetraols (see Table I ), which indicates that in their adopted conformation the fjord region protons suffer from a greater edge deshielding than in those adopted by the (r,t,c,t)-tetraols (cf. Figure 3) . The size of the coupling constants for the methine protons of the three series of stereoisomeric tetraols revealed that, in principal, the preferred adopted conformations were similar to those described earlier for analogous bay region derivatives (49) . Thus, the (r,t,t,c)-tetraols can adopt two stable interconvertable half-chair conformations as shown in Figure 2 . Large values for J a,b (7.6-7.9 Hz) and small values for J b,c (2.6-2.8 Hz) and J c,d (4.3-4.5 Hz) were observed, which indicate a preferentially adopted half-chair conformation with a pseudo-diaxial orientation of the protons H a and H b and a pseudo-diequatorial orientation of the protons H c and H d (Figure 2; conformation A) . In contrast, the situation is more complicated for the (r,t,c,c)-and (r,t,c,t)-tetraols derived from the fjord region syn-dihydrodiol epoxides. In principal the (r,t,c,c)-tetraols can again exist in an equilibrium of two half-chair conformations (Figure 3 (44), the intermediate syn-dihydrodiol epoxides formed from the three PAH investigated in the present study were hydrolyzed under acidic conditions upon work-up of incubations (perchloric acid; pH 2-3) to both the (r,t,c,c)-and (r,t,c,t)-tetraols by cisand trans-attack of water. In contrast, acidic hydrolysis of the corresponding anti-dihydrodiol epoxides yielded only the trans-opened products, the (r,t,t,c)-tetraols. Therefore, calculation of the relative amounts of the syn-and anti-dihydrodiol epoxides of each of the PAH tested was possible, despite the co-elution of their trans-opened tetraols, the (r,t,c,t)-and (r,t,t,c)-isomers (peaks A in Figure 4 ). Prior determination of the ratios of cis-to trans-opened tetraol formed from the syn-dihydrodiol epoxides under the conditions used during incubation (without microsomes) and work-up, allowed the calculation of the amount of the individual syn-and antidiastereomers. It should be noted that the amounts of measured tetraols could somewhat differ from the quantity of the Metabolites and synthetic standards were separated by HPLC using a LiChrospher-100 RP-18 (5 µm) column (4ϫ250 mm). Elution conditions were as follows: linear gradient of acetonitrile/methanol/water (10:30:60, v/ v/v) in 100 min to methanol at a flow rate of 0.8 ml/min. Incubations with microsomes were performed with amounts equivalent to 2.5 nmol cytochrome P450/ml (for further experimental details see Materials and methods). Arrows depict retention times of tetraols: A, (r,t,t,c)-and (r,t,c,t)-tetraols; B, (r,t,c,c)-tetraol (cf. Figure 1) . Q has been shown to co-elute with the o-quinones formed from the respective dihydrodiol (B[c]C-9,10-, B[g]C-11,12-and DB[a,l]P-11,12-quinone, respectively). The metabolite marked with an asterisk (*) in each chromatogram co-elutes with a product of further conversion of the fjord region anti-dihydrodiol epoxide formed during metabolism of its dihydrodiol precursor (cf. Results and discussion section).
Metabolism of B[c]C-trans-9,10-, B[g]C-trans-11,12-and DB[a,l]P-trans-11,12-dihydrodiol
corresponding dihydrodiol epoxides formed during incubation. Covalent interaction of the dihydrodiol epoxide intermediates with proteins (57) or other nucleophilic constituents, as observed with B[a]PDE or further enzymatic conversion (58) , could result in underestimation of the amount of metabolically formed dihydrodiol epoxides. The reaction of the dihydrodiol epoxides investigated in the present study with cellular nucleophiles during incubation could be excluded by incubating them with heat-denatured microsomes: no differences between the expected amount of tetraols formed after incubation with boiled microsomes or buffer alone was observed (data not shown). However, incubation of synthetic fjord region synand anti-dihydrodiol epoxides of all three PAH with microsomes under the same conditions used for the individual dihydrodiol precursor (cf. Materials and methods) revealed their conversion to several metabolites besides the later eluting 645 tetraols. However, for each individual dihydrodiol tested in the present study only one product of this further conversion of the corresponding tetraols was always detectable in significant amounts after prolonged periods of incubation (30 and 60 min). Irrespective of the dihydrodiol used as substrate, these metabolites have been identified by co-chromatography as compounds derived from the corresponding fjord region antidihydrodiol epoxides eluting very early between 13 and 20 min under the conditions used ( Figure 4 : the particular metabolite is marked by an asterisk). Table III Table III ). The extraordinarily small degree of this metabolic conversion is also evident by comparison with known data on the biotransformation of corresponding precursor dihydrodiols of B[a]P, B[a]A and B[c]Ph, respectively, catalyzed by liver microsomes of MC-treated rats (Table III) . For example, metabolic transformation of B[c]Ph-3,4-dihydrodiol to EtOAc-extractable metabolites during the first 10 min of incubation was~19-fold higher compared with DB[a,l]P-11,12-dihydrodiol (66.0 versus 3.4 nmol/nmol CYP/10 min). However, the metabolic conversion of DB[a,l]P-11,12-dihydrodiol to the corresponding anti-dihydrodiol epoxide was strongly time-dependent because of its extremely small turnover rate (3.4 Ϯ 1.0 nmol substrate/nmol CYP/10 min). After an incubation time of 60 min,~35% of the total metabolites found in the organic phase had been identified to be the (r,t,t,c)-tetraol formed as the hydrolysis product of the anti-DB[a,l]PDE (Table III) .
The present study also demonstrates that B (Table  III; (32) (33) (34) , which indicates species-specific differences and/or differences in the stereoselectivities of the metabolically competent CYP (50) . Similarly, activation of B[c]Ph-3,4-dihydrodiol has also been found to produce stereoselectively the anti-B[c]PhDE in MCF-7 cells and in the skin of SENCAR mice (19, 62) . Contrary to these findings, B[c]Ph-3,4-dihydrodiol has been found in a different study to be transformed to fjord region dihydrodiol epoxides with an excess of the syndiastereomer by liver microsomes of MC-treated rats [(44), see also Table III ]. These differences could be explained by a different composition of various CYP isoenzymes in the metabolizing system and in liver microsomes of rats after treatment with Aroclor 1254. On the other hand, it is possible that differences in rates and stereoselectivities of metabolic conversion are caused by structure-inherent properties of the substrates. Further studies are needed to clarify these points.
In conclusion, the present study demonstrates that the trans-11,12-dihydrodiols of B[g]C and DB[a,l]P as well as B[c]Ctrans-9,10-dihydrodiol are metabolically activated by liver microsomes from Aroclor 1254-treated rats to fjord region dihydrodiol epoxides. Their formation catalyzed by the contributing rat CYP isoenzymes occurs with a remarkable high degree of stereoselectivity to yield predominantly the antidiastereomers. Combined with the available data from DNA adduct investigations, the high intrinsic mutagenic activity of B 
